GLP-1–targeted therapies for alcohol and other substance use disorders: a new era on the horizon?
Lorenzo Leggio, W. Kyle Simmons · 2026
Read GLP-1–targeted therapies for alcohol and other substance use disorders: a new era on the horizon? by Lorenzo Leggio, W. Kyle Simmons (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13528915.txt.
Description
Lorenzo Leggio and Kyle Simmons argue GLP-1 drugs may treat addiction, in a viewpoint from 2026. Substance use disorders drive heavy death and illness loads despite current care options. Approved drugs exist for alcohol, opioid, and tobacco disorders, but too few patients respond well.
Brain paths for drug seeking overlap strongly with paths for food seeking and eating. GLP-1 signals sit inside that shared gut brain wiring for both drives. Across animal models, GLP-1 drugs cut drug intake and relapse like behaviour. Human records and brain scans add early support for the same effect in people. Trials must now test whether the class earns a place in addiction care.
Catalog record
| CREATOR | Lorenzo Leggio, W. Kyle Simmons |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |